160 related articles for article (PubMed ID: 30873729)
1. An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.
Carrigan G; Whipple S; Taylor MD; Torres AZ; Gossai A; Arnieri B; Tucker M; Hofmeister PP; Lambert P; Griffith SD; Capra WB
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):572-581. PubMed ID: 30873729
[TBL] [Abstract][Full Text] [Related]
2. Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.
Carrigan G; Whipple S; Capra WB; Taylor MD; Brown JS; Lu M; Arnieri B; Copping R; Rothman KJ
Clin Pharmacol Ther; 2020 Feb; 107(2):369-377. PubMed ID: 31350853
[TBL] [Abstract][Full Text] [Related]
3. Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer.
Griffith SD; Tucker M; Bowser B; Calkins G; Chang CJ; Guardino E; Khozin S; Kraut J; You P; Schrag D; Miksad RA
Adv Ther; 2019 Aug; 36(8):2122-2136. PubMed ID: 31140124
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a High-Quality Composite Real-World Mortality Endpoint.
Curtis MD; Griffith SD; Tucker M; Taylor MD; Capra WB; Carrigan G; Holzman B; Torres AZ; You P; Arnieri B; Abernethy AP
Health Serv Res; 2018 Dec; 53(6):4460-4476. PubMed ID: 29756355
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.
Griffith SD; Miksad RA; Calkins G; You P; Lipitz NG; Bourla AB; Williams E; George DJ; Schrag D; Khozin S; Capra WB; Taylor MD; Abernethy AP
JCO Clin Cancer Inform; 2019 Aug; 3():1-13. PubMed ID: 31403818
[TBL] [Abstract][Full Text] [Related]
6. Commentary in response to Carrigan et al: "An Evaluation of the Impact of Missing Deaths on Overall Survival Analyses of Advanced Non-small Cell Lung Cancer Patients Conducted in an Electronic Health Records Database".
Wang SV
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):582-583. PubMed ID: 30873670
[No Abstract] [Full Text] [Related]
7. Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence.
Chen Y; Wang J; Chubak J; Hubbard RA
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):264-268. PubMed ID: 30375122
[TBL] [Abstract][Full Text] [Related]
8. Agreement and validity of electronic health record prescribing data relative to pharmacy claims data: A validation study from a US electronic health record database.
Rowan CG; Flory J; Gerhard T; Cuddeback JK; Stempniewicz N; Lewis JD; Hennessy S
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):963-972. PubMed ID: 28608510
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data.
Sperrin M; Webb DJ; Patel P; Davis KJ; Collier S; Pate A; Leather DA; Pimenta JM
Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1369-1376. PubMed ID: 31385428
[TBL] [Abstract][Full Text] [Related]
10. A method for cohort selection of cardiovascular disease records from an electronic health record system.
Abrahão MTF; Nobre MRC; Gutierrez MA
Int J Med Inform; 2017 Jun; 102():138-149. PubMed ID: 28495342
[TBL] [Abstract][Full Text] [Related]
11. Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record-Derived Real-World Data.
Tan K; Bryan J; Segal B; Bellomo L; Nussbaum N; Tucker M; Torres AZ; Bennette C; Capra W; Curtis M; Miksad RA
Clin Pharmacol Ther; 2022 Jan; 111(1):168-178. PubMed ID: 34197637
[TBL] [Abstract][Full Text] [Related]
12. Real-world anaplastic lymphoma kinase (ALK) rearrangement testing patterns, treatment sequences, and survival of ALK inhibitor-treated patients.
Davies J; Martinec M; Coudert M; Delmar P; Crane G
Curr Med Res Opin; 2019 Mar; 35(3):535-542. PubMed ID: 30296185
[TBL] [Abstract][Full Text] [Related]
13. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
Singal G; Miller PG; Agarwala V; Li G; Kaushik G; Backenroth D; Gossai A; Frampton GM; Torres AZ; Lehnert EM; Bourque D; O'Connell C; Bowser B; Caron T; Baydur E; Seidl-Rathkopf K; Ivanov I; Alpha-Cobb G; Guria A; He J; Frank S; Nunnally AC; Bailey M; Jaskiw A; Feuchtbaum D; Nussbaum N; Abernethy AP; Miller VA
JAMA; 2019 Apr; 321(14):1391-1399. PubMed ID: 30964529
[TBL] [Abstract][Full Text] [Related]
14. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
Young KA; Efiong E; Dove JT; Blansfield JA; Hunsinger MA; Wild JL; Shabahang MM; Facktor MA
Ann Surg Oncol; 2017 Jun; 24(6):1459-1464. PubMed ID: 28168388
[TBL] [Abstract][Full Text] [Related]
15. Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studies.
Adamson BJS; Ma X; Griffith SD; Sweeney EM; Sarkar S; Bourla AB
Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):46-54. PubMed ID: 34227170
[TBL] [Abstract][Full Text] [Related]
16. Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.
Khozin S; Carson KR; Zhi J; Tucker M; Lee SE; Light DE; Curtis MD; Bralic M; Kaganman I; Gossai A; Hofmeister P; Torres AZ; Miksad RA; Blumenthal GM; Pazdur R; Abernethy AP
Oncologist; 2019 May; 24(5):648-656. PubMed ID: 30591549
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom.
Cea Soriano L; Zong J; García Rodríguez LA
BMC Cancer; 2019 Jan; 19(1):91. PubMed ID: 30665371
[TBL] [Abstract][Full Text] [Related]
18. Validation of diagnosis codes to identify side of colon in an electronic health record registry.
Luhn P; Kuk D; Carrigan G; Nussbaum N; Sorg R; Rohrer R; Tucker MG; Arnieri B; Taylor MD; Meropol NJ
BMC Med Res Methodol; 2019 Aug; 19(1):177. PubMed ID: 31426736
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.
Marcus PM; Bergstralh EJ; Fagerstrom RM; Williams DE; Fontana R; Taylor WF; Prorok PC
J Natl Cancer Inst; 2000 Aug; 92(16):1308-16. PubMed ID: 10944552
[TBL] [Abstract][Full Text] [Related]
20. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis.
Hardtstock F; Myers D; Li T; Cizova D; Maywald U; Wilke T; Griesinger F
BMC Cancer; 2020 Mar; 20(1):260. PubMed ID: 32228520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
